Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-020613

Chief Commercial Officer gave up 34,165 shares (to pay taxes)

  • Chief Commercial Officer acquired 120,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kirby Daniel Gordon · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-24 Exercise or conversion : show line 1 in the form +120,000 173,546 D
2026-02-24 Shares withheld for taxes : show line 2 in the form −34,165 $3.78 $129,144 139,381 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-24 Exercise or conversion : show line 3 in the form Restricted Stock Units −150,000 0 D
Loading xslF345X05/tm267318-1_4seq1.xml…